{"id":950726,"date":"2026-04-13T08:05:14","date_gmt":"2026-04-13T12:05:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\/"},"modified":"2026-04-13T08:05:14","modified_gmt":"2026-04-13T12:05:14","slug":"geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\/","title":{"rendered":"Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary"},"content":{"rendered":"<h2>\nTim is a seasoned legal executive bringing extensive experience supporting commercial biopharmaceutical companies<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>FOSTER CITY, Calif., April  13, 2026  (GLOBE NEWSWIRE) &#8212; Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced the appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary.<\/p>\n<p>\u201cTim has deep expertise in the biopharmaceutical industry and a proven track record of leading the legal function at commercial-stage organizations,\u201d said Harout Semerjian, President and Chief Executive Officer of Geron. \u201cThe addition of Tim, coupled with our recent Board appointments, further strengthens our leadership team. His strategic counsel will be invaluable as we advance our strategy to build a leading, sustainable hematology company.\u201d<\/p>\n<p>\u201cGeron has a differentiated treatment option for lower-risk myelodysplastic syndromes\/neoplasms and a compelling commercial strategy that positions the Company for long-term sustainable growth,\u201d said Mr. Williams. \u201cI\u2019m excited to work with this team to help deliver on Geron\u2019s strategic priorities and drive value creation for patients and shareholders.\u201d<\/p>\n<p>Tim Williams served as Senior Vice President, General Counsel and Secretary at Vanda Pharmaceuticals from 2018 until March 2026. Prior to joining Vanda, Mr. Williams served as Executive Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary at AgNovos Bioscience. Prior to this position, Mr. Williams was Senior Legal Counsel and Assistant Secretary at Stryker Corporation, where he led the legal department\u2019s global M&amp;A, corporate governance, and securities groups. Before joining Stryker, Mr. Williams practiced law in Chicago at Mayer Brown and Bryan Cave. He received his Juris Doctor from the University of Michigan and his bachelor\u2019s and master\u2019s degrees from Western Michigan University.<\/p>\n<p>\n        <strong>About Geron<\/strong><br \/>\n        <br \/>Geron is a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer. Our first-in-class telomerase inhibitor RYTELO<sup>\u00ae<\/sup> (imetelstat) is approved in the United States and the European Union for the treatment of certain adult patients with lower-risk myelodysplastic syndromes with transfusion dependent anemia. We are also conducting a pivotal Phase 3 clinical trial of imetelstat in JAK-inhibitor relapsed\/refractory myelofibrosis, as well as studies in other hematologic malignancies. Inhibiting telomerase activity, which is increased in malignant stem and progenitor cells in the bone marrow, aims to potentially reduce proliferation and induce death of malignant cells. To learn more, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2snkFnSnFL1z-CGpWgXN7DcN72zczI1Np4r3NcMU24B_S2yzfm2HLL-fBJcT0ndbrx-_W_hNvv7CyUrGYK_-rQ==\" rel=\"nofollow\" target=\"_blank\">www.geron.com<\/a>\u00a0or follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JbrAuP_Sjdv83GMJM2pqkGs5ruaA9Nge7gjXuiyjB2rWC04R16hb2WYdgTujLwteEigiPn4R3YW-Gtjrr86TTU_6tl-n7iCFdDe16Xl2Q8Q=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Use of Forward-Looking Statements<\/strong>\n      <\/p>\n<p>Except for the historical information\u00a0contained\u00a0herein, this press release\u00a0contains\u00a0forward-looking statements made\u00a0pursuant to\u00a0the \u201csafe harbor\u201d provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such statements, include, without limitation, those regarding: (i) Geron\u2019s ability to advance its strategy to build a leading, sustainable hematology company; (ii) Geron\u2019s commercial strategy positioning it for long term sustainable growth; (iii) Geron delivering on its strategic priorities and driving value creation for patients and shareholders; and (v) and other statements that are not historical facts, constitute forward-looking statements.\u00a0 These forward-looking statements involve risks and uncertainties that can cause actual results to differ materially from those in such forward-looking statements. These risks and uncertainties, include, without limitation, risks and uncertainties related to: (a) whether Geron is successful in commercializing RYTELO for the treatment of certain patients with lower-risk MDS with transfusion dependent anemia and achieves market acceptance across the breadth of the eligible patient segments in RYTELO\u2019s approved indication; (b) whether the FDA and European Commission will approve\u00a0imetelstat\u00a0for other indications on the timelines expected, or at all; (c) Geron\u2019s plans to commercialize RYTELO outside of the U.S. and risks related to operating outside of the U.S.; (d) Geron\u2019s future opportunities and plans, including the uncertainty of future revenues, expenses and other financial performance and results; (e) whether Geron overcomes potential delays and other adverse impacts that may be caused by enrollment, clinical, safety, efficacy, technical, scientific, intellectual property, manufacturing, regulatory and healthcare challenges in order to have the financial resources for and meet expected timelines and planned milestones; (f) whether regulatory authorities permit the further development of\u00a0imetelstat\u00a0on a timely basis, or at all, without any clinical holds; (g) whether any future safety or efficacy results of RYTELO treatment cause its benefit-risk profile to become unacceptable; (h) whether\u00a0imetelstat\u00a0actually demonstrates disease-modifying activity in patients and the ability to target the malignant stem and progenitor cells of the underlying disease; (i) whether Geron meets its post-marketing requirements and commitments for RYTELO; and (j) whether there are failures or delays in manufacturing or supplying sufficient quantities of RYTELO (imetelstat) or other clinical trial materials that impact commercialization of RYTELO or the continuation of clinical trials. Additional information on the above risks and uncertainties and additional risks, uncertainties and factors that could cause actual results to differ materially from those in the forward-looking statements are contained in Geron\u2019s filings and periodic reports filed with the Securities and Exchange Commission under the heading \u201cRisk Factors\u201d and elsewhere in such filings and reports, including Geron\u2019s annual report on Form 10-K for the year ended December 31, 2025. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made, and the facts and assumptions underlying the forward-looking statements may change. Except as required by law, Geron\u00a0disclaims\u00a0any obligation to update these forward-looking statements to reflect future information, events, or circumstances.<\/p>\n<p>\n        <strong>Investors and Media<\/strong><br \/>\n        <br \/>Dawn Schottlandt<br \/>Senior Vice President, Investor Relations and Corporate Affairs<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RMjSvbBPJhrvsizQTECI9x1tZBt6gi4WWmib5yhiO5HC3pepYnYz0LtbNcWa1s_PT_C8af6WnN1S40Qf_AqRNvUfMBJulwpdcH0c5SvHj04=\" rel=\"nofollow\" target=\"_blank\">dschottlandt@geron.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NzU1MSM3NTI3ODE2IzIwMTE0NjE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjZhODNmNjQtOTk3Ni00YzM3LWFlNjYtNWFiZjkzMjZkYWZmLTEwMjMwMzQtMjAyNi0wNC0xMy1lbg==\/tiny\/Geron-Corporation.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Tim is a seasoned legal executive bringing extensive experience supporting commercial biopharmaceutical companies FOSTER CITY, Calif., April 13, 2026 (GLOBE NEWSWIRE) &#8212; Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced the appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary. \u201cTim has deep expertise in the biopharmaceutical industry and a proven track record of leading the legal function at commercial-stage organizations,\u201d said Harout Semerjian, President and Chief Executive Officer of Geron. \u201cThe addition of Tim, coupled with our recent Board appointments, further strengthens our leadership team. His strategic counsel will be invaluable as we advance our strategy to build a leading, sustainable &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-950726","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Tim is a seasoned legal executive bringing extensive experience supporting commercial biopharmaceutical companies FOSTER CITY, Calif., April 13, 2026 (GLOBE NEWSWIRE) &#8212; Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced the appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary. \u201cTim has deep expertise in the biopharmaceutical industry and a proven track record of leading the legal function at commercial-stage organizations,\u201d said Harout Semerjian, President and Chief Executive Officer of Geron. \u201cThe addition of Tim, coupled with our recent Board appointments, further strengthens our leadership team. His strategic counsel will be invaluable as we advance our strategy to build a leading, sustainable &hellip; Continue reading &quot;Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-13T12:05:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NzU1MSM3NTI3ODE2IzIwMTE0NjE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary\",\"datePublished\":\"2026-04-13T12:05:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\\\/\"},\"wordCount\":924,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NzU1MSM3NTI3ODE2IzIwMTE0NjE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\\\/\",\"name\":\"Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NzU1MSM3NTI3ODE2IzIwMTE0NjE=\",\"datePublished\":\"2026-04-13T12:05:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NzU1MSM3NTI3ODE2IzIwMTE0NjE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NzU1MSM3NTI3ODE2IzIwMTE0NjE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\/","og_locale":"en_US","og_type":"article","og_title":"Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary - Market Newsdesk","og_description":"Tim is a seasoned legal executive bringing extensive experience supporting commercial biopharmaceutical companies FOSTER CITY, Calif., April 13, 2026 (GLOBE NEWSWIRE) &#8212; Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced the appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary. \u201cTim has deep expertise in the biopharmaceutical industry and a proven track record of leading the legal function at commercial-stage organizations,\u201d said Harout Semerjian, President and Chief Executive Officer of Geron. \u201cThe addition of Tim, coupled with our recent Board appointments, further strengthens our leadership team. His strategic counsel will be invaluable as we advance our strategy to build a leading, sustainable &hellip; Continue reading \"Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-13T12:05:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NzU1MSM3NTI3ODE2IzIwMTE0NjE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary","datePublished":"2026-04-13T12:05:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\/"},"wordCount":924,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NzU1MSM3NTI3ODE2IzIwMTE0NjE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\/","name":"Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NzU1MSM3NTI3ODE2IzIwMTE0NjE=","datePublished":"2026-04-13T12:05:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NzU1MSM3NTI3ODE2IzIwMTE0NjE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NzU1MSM3NTI3ODE2IzIwMTE0NjE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geron-announces-appointment-of-timothy-williams-as-executive-vice-president-chief-legal-officer-and-corporate-secretary\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/950726","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=950726"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/950726\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=950726"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=950726"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=950726"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}